| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.874 | 0.003 | 0.874 | 5 Hydroxytryptamine release inhibitor | 0.547 0.02 CID_11522049 | ||
| 0.785 | 0.004 | 0.785 | Histamine release inhibitor | 0.752 0.004 CID_11522049 | ||
| 0.629 | 0.004 | 0.655 | NMDA receptor antagonist | 0.655 0.003 CID_11522049 | CID_11522049 | |
| 0.618 | 0.017 | 0.618 | Aldehyde oxidase inhibitor | |||
| 0.587 | 0.007 | 0.587 | Calcium channel L-type activator | 0.486 0.033 CID_11522049 | ||
| 0.563 | 0.026 | 0.601 | Antibacterial | 0.601 0.019 CID_11522049 | CID_11522049 | |
| 0.548 | 0.015 | 0.548 | GABA C receptor rho-3 antagonist | 0.22 0.184 CID_11522049 | ||
| 0.514 | 0.022 | 0.514 | Aryl hydrocarbon receptor agonist | |||
| 0.486 | 0.003 | 0.486 | NMDA receptor subunit 3A antagonist | 0.047 0.021 CID_11522049 | ||
| 0.478 | 0.004 | 0.62 | NMDA 2 receptor antagonist | 0.62 0.003 CID_11522049 | CID_11522049 | |
| 0.433 | 0.003 | 0.433 | NMDA receptor subunit 3B antagonist | |||
| 0.428 | 0.004 | 0.428 | Alcohol oxidase inhibitor | |||
| 0.414 | 0.02 | 0.414 | DNA synthesis inhibitor | 0.278 0.052 CID_11522049 | ||
| 0.396 | 0.003 | 0.396 | NMDA 2C receptor antagonist | 0.322 0.004 CID_11522049 | ||
| 0.41 | 0.019 | 0.41 | Peroxidase inhibitor | 0.133 0.088 CID_11522049 | ||
| 0.443 | 0.056 | 0.443 | 15-Lipoxygenase inhibitor | 0.315 0.121 CID_11522049 | ||
| 0.377 | 0.006 | 0.377 | Glutamate receptor antagonist | 0.287 0.011 CID_11522049 | ||
| 0.396 | 0.026 | 0.396 | Calcium channel activator | 0.274 0.119 CID_11522049 | ||
| 0.365 | 0.004 | 0.365 | Porphobilinogen synthase inhibitor | 0.117 0.029 CID_11522049 | ||
| 0.377 | 0.029 | 0.377 | Amyloid beta aggregation inhibitor | |||
| 0.433 | 0.098 | 0.433 | Apoptosis agonist | 0.265 0.199 CID_11522049 | ||
| 0.361 | 0.034 | 0.493 | Superoxide dismutase inhibitor | 0.493 0.014 CID_11522049 | CID_11522049 | |
| 0.328 | 0.004 | 0.328 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.126 0.027 CID_11522049 | ||
| 0.36 | 0.037 | 0.36 | Free radical scavenger | 0.206 0.093 CID_11522049 | ||
| 0.323 | 0.004 | 0.323 | NMDA 2A receptor antagonist | 0.231 0.004 CID_11522049 | ||
| 0.337 | 0.019 | 0.337 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.356 | 0.045 | 0.375 | Antioxidant | 0.375 0.04 CID_11522049 | CID_11522049 | |
| 0.319 | 0.008 | 0.319 | GABA C receptor agonist | 0.105 0.062 CID_11522049 | ||
| 0.358 | 0.048 | 0.358 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.313 | 0.004 | 0.313 | Creatine kinase inhibitor | 0.173 0.016 CID_11522049 | ||
| 0.323 | 0.016 | 0.323 | Monophenol monooxygenase inhibitor | 0.178 0.038 CID_11522049 | ||
| 0.314 | 0.02 | 0.314 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.296 | 0.011 | 0.296 | Chelator | 0.104 0.072 CID_11522049 | ||
| 0.291 | 0.006 | 0.291 | GABA C receptor rho-2 antagonist | 0.133 0.1 CID_11522049 | ||
| 0.357 | 0.075 | 0.357 | Transcription factor NF kappa B inhibitor | 0.213 0.157 CID_11522049 | ||
| 0.318 | 0.037 | 0.318 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.307 | 0.027 | 0.473 | Dual specificity phosphatase inhibitor | 0.473 0.008 CID_11522049 | CID_11522049 | |
| 0.278 | 0.004 | 0.278 | Glutamate decarboxylase inhibitor | 0.148 0.013 CID_11522049 | ||
| 0.341 | 0.068 | 0.51 | Cholesterol antagonist | 0.51 0.031 CID_11522049 | CID_11522049 | |
| 0.387 | 0.119 | 0.387 | Caspase 9 stimulant | |||
| 0.317 | 0.051 | 0.317 | DNA damaging | |||
| 0.275 | 0.019 | 0.275 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.253 | 0.002 | 0.253 | NMDA receptor glycine site antagonist | 0.038 0.009 CID_11522049 | ||
| 0.314 | 0.064 | 0.314 | Lipoxygenase inhibitor | |||
| 0.337 | 0.089 | 0.337 | Toll-Like receptor 7 agonist | |||
| 0.259 | 0.014 | 0.259 | Cystathionine beta-synthase inhibitor | |||
| 0.26 | 0.023 | 0.26 | Topoisomerase II inhibitor | 0.137 0.056 CID_11522049 | ||
| 0.33 | 0.093 | 0.33 | Toll-Like receptor agonist | |||
| 0.31 | 0.075 | 0.31 | Streptokinase A inhibitor | |||
| 0.321 | 0.087 | 0.321 | Vasodilator, peripheral | |||
| 0.25 | 0.022 | 0.25 | Succinate dehydrogenase inhibitor | 0.182 0.065 CID_11522049 | ||
| 0.288 | 0.066 | 0.288 | Insulysin inhibitor | |||
| 0.223 | 0.005 | 0.223 | GABA C receptor rho-1 antagonist | 0.088 0.081 CID_11522049 | ||
| 0.218 | 0.01 | 0.218 | GABA C receptor antagonist | 0.167 0.022 CID_11522049 | ||
| 0.265 | 0.057 | 0.265 | Pyruvate kinase inhibitor | |||
| 0.217 | 0.012 | 0.217 | Mediator release inhibitor | |||
| 0.227 | 0.026 | 0.227 | NADPH oxidase inhibitor | |||
| 0.22 | 0.021 | 0.22 | Alkylator | 0.16 0.042 CID_11522049 | ||
| 0.247 | 0.051 | 0.368 | RNA-directed DNA polymerase inhibitor | 0.368 0.022 CID_11522049 | CID_11522049 | |
| 0.208 | 0.017 | 0.208 | UDP-glucose 4-epimerase inhibitor | |||
| 0.231 | 0.042 | 0.231 | Mcl-1 antagonist | |||
| 0.199 | 0.013 | 0.199 | Uric acid excretion stimulant | 0.091 0.063 CID_11522049 | ||
| 0.224 | 0.039 | 0.224 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.195 | 0.013 | 0.195 | Beta glucuronidase inhibitor | 0.1 0.07 CID_11522049 | ||
| 0.217 | 0.035 | 0.217 | Lipid peroxidase inhibitor | 0.15 0.068 CID_11522049 | ||
| 0.199 | 0.019 | 0.199 | Xanthine oxidase inhibitor | |||
| 0.209 | 0.03 | 0.209 | ATPase inhibitor | |||
| 0.338 | 0.164 | 0.338 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.271 | 0.097 | 0.271 | 12-Lipoxygenase inhibitor | |||
| 0.202 | 0.029 | 0.367 | Cell wall synthesis inhibitor | 0.367 0.007 CID_11522049 | CID_11522049 | |
| 0.213 | 0.042 | 0.359 | Protein-tyrosine phosphatase inhibitor | 0.359 0.011 CID_11522049 | CID_11522049 | |
| 0.178 | 0.009 | 0.178 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.184 | 0.015 | 0.184 | Histidine decarboxylase inhibitor | |||
| 0.196 | 0.028 | 0.196 | Topoisomerase I inhibitor | 0.087 0.082 CID_11522049 | ||
| 0.17 | 0.006 | 0.249 | NMDA receptor agonist | 0.249 0.004 CID_11522049 | CID_11522049 | |
| 0.244 | 0.081 | 0.244 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.17 | 0.013 | 0.17 | DOPA decarboxylase inhibitor | |||
| 0.18 | 0.027 | 0.18 | Ferrochelatase inhibitor | |||
| 0.169 | 0.019 | 0.169 | Heat shock protein 70 antagonist | |||
| 0.152 | 0.004 | 0.152 | NMDA receptor glycine site agonist | 0.093 0.02 CID_11522049 | ||
| 0.229 | 0.082 | 0.229 | Antiamyloidogenic | |||
| 0.185 | 0.04 | 0.185 | Alkaline phosphatase inhibitor | 0.172 0.046 CID_11522049 | ||
| 0.303 | 0.158 | 0.303 | Alpha-glucosidase inhibitor | |||
| 0.187 | 0.043 | 0.187 | Hexokinase inhibitor | |||
| 0.177 | 0.034 | 0.177 | Aldehyde dehydrogenase inhibitor | |||
| 0.181 | 0.042 | 0.181 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.145 | 0.006 | 0.145 | Maillard reaction inhibitor | |||
| 0.157 | 0.018 | 0.42 | Triose-phosphate isomerase inhibitor | 0.42 0.003 CID_11522049 | CID_11522049 | |
| 0.184 | 0.047 | 0.184 | Catenin beta inhibitor | |||
| 0.153 | 0.017 | 0.153 | NADH dehydrogenase inhibitor | 0.098 0.046 CID_11522049 | ||
| 0.227 | 0.092 | 0.227 | Hypoglycemic | |||
| 0.168 | 0.034 | 0.168 | Antibacterial (Helicobacter pylori) | 0.139 0.057 CID_11522049 | ||
| 0.232 | 0.099 | 0.232 | Transcription factor STAT3 inhibitor | |||
| 0.157 | 0.024 | 0.157 | Adenylate kinase inhibitor | 0.113 0.05 CID_11522049 | ||
| 0.183 | 0.05 | 0.183 | Amylase inhibitor | |||
| 0.16 | 0.028 | 0.16 | Bronchodilator | |||
| 0.158 | 0.027 | 0.158 | Ca2+-transporting ATPase inhibitor | |||
| 0.145 | 0.015 | 0.145 | Keratolytic | |||
| 0.253 | 0.124 | 0.253 | Sodium/bile acid cotransporter inhibitor | 0.226 0.155 CID_11522049 | ||
| 0.213 | 0.085 | 0.213 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.154 | 0.026 | 0.154 | Potassium channel (Ca-activated) activator | |||
| 0.186 | 0.058 | 0.186 | Heat shock protein 90 alpha antagonist | |||
| 0.179 | 0.052 | 0.179 | Acetylcholine M1 receptor antagonist | |||
| 0.179 | 0.055 | 0.179 | Arachidonic acid antagonist | |||
| 0.188 | 0.068 | 0.41 | Dual specificity phosphatase 3 inhibitor | 0.41 0.013 CID_11522049 | CID_11522049 | |
| 0.252 | 0.132 | 0.252 | Vasodilator, coronary | |||
| 0.132 | 0.013 | 0.189 | Glycine receptor antagonist | 0.189 0.004 CID_11522049 | CID_11522049 | |
| 0.134 | 0.019 | 0.134 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.146 | 0.031 | 0.146 | AMP-activated protein kinase stimulant | |||
| 0.144 | 0.033 | 0.144 | Carbonic anhydrase XV inhibitor | 0.104 0.062 CID_11522049 | ||
| 0.14 | 0.03 | 0.14 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.168 | 0.058 | 0.168 | Interferon gamma antagonist | |||
| 0.176 | 0.066 | 0.208 | Phospholipase C inhibitor | 0.208 0.039 CID_11522049 | CID_11522049 | |
| 0.22 | 0.112 | 0.22 | Transcription factor STAT inhibitor | |||
| 0.119 | 0.011 | 0.119 | CDC25B inhibitor | |||
| 0.141 | 0.032 | 0.141 | Carbonic anhydrase III inhibitor | 0.118 0.045 CID_11522049 | ||
| 0.118 | 0.011 | 0.118 | Xanthine dehydrogenase inhibitor | |||
| 0.124 | 0.018 | 0.231 | CDC25A inhibitor | 0.231 0.005 CID_11522049 | CID_11522049 | |
| 0.238 | 0.133 | 0.238 | Interleukin 2 agonist | |||
| 0.153 | 0.047 | 0.153 | Interleukin 4 antagonist | |||
| 0.132 | 0.027 | 0.132 | Alcohol dehydrogenase inhibitor | |||
| 0.114 | 0.008 | 0.114 | Dihydroorotate dehydrogenase inhibitor | 0.068 0.023 CID_11522049 | ||
| 0.177 | 0.073 | 0.177 | Lipocortins synthesis antagonist | |||
| 0.135 | 0.032 | 0.135 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.108 | 0.004 | 0.108 | Dihydroorotate oxidase inhibitor | 0.069 0.018 CID_11522049 | ||
| 0.119 | 0.017 | 0.119 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.149 | 0.05 | 0.149 | DNA polymerase I inhibitor | |||
| 0.159 | 0.061 | 0.159 | CF transmembrane conductance regulator agonist | |||
| 0.123 | 0.024 | 0.123 | Macrophage migration inhibitory factor inhibitor | |||
| 0.113 | 0.016 | 0.113 | Argininosuccinate synthase inhibitor | |||
| 0.162 | 0.067 | 0.162 | Melanin inhibitor | |||
| 0.109 | 0.014 | 0.109 | Purinergic P2X1 antagonist | |||
| 0.208 | 0.114 | 0.208 | 5 Hydroxytryptamine release stimulant | |||
| 0.143 | 0.049 | 0.214 | Protein-tyrosine phosphatase 1B inhibitor | 0.214 0.025 CID_11522049 | CID_11522049 | |
| 0.217 | 0.123 | 0.217 | Gastrin inhibitor | |||
| 0.177 | 0.083 | 0.288 | Hepatoprotectant | 0.288 0.033 CID_11522049 | CID_11522049 | |
| 0.221 | 0.128 | 0.221 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.112 | 0.019 | 0.112 | Potassium channel large-conductance Ca-activated activator | |||
| 0.126 | 0.034 | 0.147 | Anabolic | 0.147 0.02 CID_11522049 | CID_11522049 | |
| 0.111 | 0.019 | 0.111 | D-Ala-D-Ala ligase inhibitor | |||
| 0.107 | 0.016 | 0.107 | DNA gyrase inhibitor | |||
| 0.098 | 0.008 | 0.098 | Cathepsin L2 inhibitor | |||
| 0.157 | 0.068 | 0.157 | Phospholipase A2 inhibitor | 0.131 0.098 CID_11522049 | ||
| 0.191 | 0.103 | 0.191 | Dyrk kinase inhibitor | |||
| 0.114 | 0.026 | 0.114 | Glutamate release inhibitor | |||
| 0.183 | 0.095 | 0.183 | Neurotrophic factor enhancer | |||
| 0.145 | 0.06 | 0.145 | Tubulin antagonist | |||
| 0.155 | 0.07 | 0.155 | Heat shock protein 90 antagonist | |||
| 0.095 | 0.011 | 0.095 | Plasminogen activator inhibitor antagonist | |||
| 0.098 | 0.015 | 0.098 | Beta 3 adrenoreceptor antagonist | |||
| 0.093 | 0.01 | 0.093 | Aconitate hydratase inhibitor | |||
| 0.099 | 0.017 | 0.099 | Beta adrenoreceptor antagonist | |||
| 0.153 | 0.075 | 0.488 | Diuretic | 0.488 0.008 CID_11522049 | CID_11522049 | |
| 0.11 | 0.036 | 0.11 | Aminoacyl-tRNA synthetase inhibitor | 0.087 0.064 CID_11522049 | ||
| 0.124 | 0.05 | 0.152 | Aminopeptidase B inhibitor | 0.152 0.037 CID_11522049 | CID_11522049 | |
| 0.092 | 0.02 | 0.092 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.186 | 0.115 | 0.186 | Nitric-oxide synthase stimulant | |||
| 0.105 | 0.034 | 0.105 | Adrenaline agonist | |||
| 0.157 | 0.086 | 0.157 | Neurotensin receptor agonist | |||
| 0.162 | 0.092 | 0.162 | DNA methyltransferase I inhibitor | |||
| 0.119 | 0.05 | 0.119 | 5-Lipoxygenase inhibitor | |||
| 0.118 | 0.049 | 0.118 | Protein kinase (CK2) inhibitor | |||
| 0.1 | 0.032 | 0.1 | Phosphofructokinase-1 inhibitor | |||
| 0.143 | 0.075 | 0.143 | Adenylate cyclase stimulant | 0.134 0.094 CID_11522049 | ||
| 0.143 | 0.077 | 0.143 | MAP kinase kinase 4 inhibitor | |||
| 0.09 | 0.025 | 0.09 | MAP kinase kinase 7 inhibitor | |||
| 0.096 | 0.033 | 0.096 | Glutamate dehydrogenase inhibitor | |||
| 0.078 | 0.017 | 0.078 | Phosphorylase inhibitor | 0.06 0.025 CID_11522049 | ||
| 0.091 | 0.031 | 0.111 | HIV-1 integrase inhibitor | 0.111 0.019 CID_11522049 | CID_11522049 | |
| 0.083 | 0.025 | 0.083 | Biliverdin reductase inhibitor | |||
| 0.074 | 0.015 | 0.074 | Topoisomerase II beta inhibitor | |||
| 0.189 | 0.131 | 0.189 | Interleukin agonist | |||
| 0.128 | 0.07 | 0.128 | Toll-Like receptor 2 antagonist | |||
| 0.091 | 0.034 | 0.091 | GABA aminotransferase inhibitor | |||
| 0.16 | 0.104 | 0.16 | Non-steroidal antiinflammatory agent | |||
| 0.187 | 0.131 | 0.187 | Spasmolytic | |||
| 0.079 | 0.024 | 0.128 | Aldose reductase inhibitor | 0.128 0.013 CID_11522049 | CID_11522049 | |
| 0.081 | 0.027 | 0.081 | Glutamate (mGluR7) antagonist | |||
| 0.116 | 0.063 | 0.116 | Estrogen antagonist | |||
| 0.184 | 0.131 | 0.299 | Immunostimulant | 0.299 0.079 CID_11522049 | CID_11522049 | |
| 0.117 | 0.064 | 0.117 | Microtubule formation inhibitor | |||
| 0.106 | 0.053 | 0.106 | Estrogen receptor beta antagonist | |||
| 0.061 | 0.009 | 0.061 | Acid-sensing ion channel blocker | |||
| 0.059 | 0.008 | 0.059 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.078 | 0.027 | 0.078 | Glutamate (mGluR6) antagonist | |||
| 0.06 | 0.011 | 0.06 | Nicotinic acid receptor 2 agonist | |||
| 0.159 | 0.11 | 0.159 | I kappa B kinase epsilon inhibitor | |||
| 0.068 | 0.02 | 0.068 | Ryanodine receptor antagonist | |||
| 0.115 | 0.068 | 0.115 | Interleukin 8 antagonist | |||
| 0.068 | 0.024 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.093 | 0.049 | 0.096 | Antineoplastic antibiotic | 0.096 0.048 CID_11522049 | CID_11522049 | |
| 0.113 | 0.07 | 0.113 | Caspase 3 inhibitor | |||
| 0.111 | 0.069 | 0.111 | Photosensitizer | |||
| 0.081 | 0.039 | 0.081 | GABA B receptor agonist | |||
| 0.054 | 0.013 | 0.067 | Farnesoid X receptor agonist | 0.067 0.008 CID_11522049 | CID_11522049 | |
| 0.143 | 0.102 | 0.144 | Nitric oxide antagonist | 0.144 0.101 CID_11522049 | CID_11522049 | |
| 0.064 | 0.023 | 0.094 | Adenine nucleotide translocase inhibitor | 0.094 0.005 CID_11522049 | CID_11522049 | |
| 0.099 | 0.06 | 0.099 | Electrolyte absorption antagonist | |||
| 0.092 | 0.054 | 0.092 | Antineoplastic alkaloid | |||
| 0.159 | 0.121 | 0.159 | Insulin sensitizer | |||
| 0.204 | 0.169 | 0.204 | Thioredoxin glutathione reductase inhibitor | |||
| 0.061 | 0.026 | 0.128 | Factor IXa inhibitor | 0.128 0.005 CID_11522049 | CID_11522049 | |
| 0.044 | 0.011 | 0.044 | Catechol O-methyltransferase inhibitor | |||
| 0.205 | 0.172 | 0.205 | Apoptosis antagonist | |||
| 0.085 | 0.052 | 0.085 | Carbonic anhydrase VI inhibitor | 0.072 0.068 CID_11522049 | ||
| 0.061 | 0.028 | 0.061 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.053 | 0.02 | 0.053 | Neuraminidase (Influenza A) inhibitor | |||
| 0.094 | 0.062 | 0.094 | Prolactin inhibitor | |||
| 0.05 | 0.018 | 0.05 | Beta adrenoreceptor agonist | |||
| 0.115 | 0.083 | 0.115 | DNA repair enzyme inhibitor | |||
| 0.05 | 0.019 | 0.05 | 5-Alpha-reductase inhibitor | |||
| 0.038 | 0.007 | 0.038 | Thyroid hormone agonist | 0.038 0.007 CID_11522049 | ||
| 0.036 | 0.007 | 0.036 | Nicotinic acid receptor 2 antagonist | |||
| 0.047 | 0.02 | 0.047 | Dopamine D5 agonist | |||
| 0.147 | 0.12 | 0.147 | DNA methylase inhibitor | |||
| 0.124 | 0.097 | 0.124 | CC chemokine 6 receptor antagonist | |||
| 0.043 | 0.018 | 0.043 | Nicotinic acid receptor agonist | |||
| 0.094 | 0.069 | 0.094 | MAO A inhibitor | |||
| 0.083 | 0.058 | 0.083 | Estrogen-related receptor beta agonist | |||
| 0.084 | 0.059 | 0.084 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.244 | 0.22 | 0.405 | Cyclophilin D inhibitor | 0.405 0.088 CID_11522049 | CID_11522049 | |
| 0.05 | 0.026 | 0.05 | Purinergic P2Y antagonist | |||
| 0.034 | 0.011 | 0.034 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.066 | 0.044 | 0.066 | Leukotriene antagonist | |||
| 0.046 | 0.024 | 0.046 | GABA B receptor antagonist | |||
| 0.064 | 0.043 | 0.204 | HIV-1 integrase (3'-Processing) inhibitor | 0.204 0.009 CID_11522049 | CID_11522049 | |
| 0.052 | 0.031 | 0.052 | CD45 antagonist | |||
| 0.098 | 0.078 | 0.098 | Protein kinase (CK2) alpha inhibitor | |||
| 0.06 | 0.04 | 0.06 | Heat shock protein 90 beta antagonist | |||
| 0.036 | 0.015 | 0.036 | Glutamate (mGluR3) agonist | |||
| 0.025 | 0.005 | 0.025 | Nicotinic acid receptor 1 antagonist | |||
| 0.041 | 0.021 | 0.041 | Glutamate (mGluR8) agonist | |||
| 0.099 | 0.079 | 0.099 | Mucolytic | |||
| 0.186 | 0.167 | 0.186 | Prostaglandin dehydrogenase inhibitor | |||
| 0.124 | 0.105 | 0.394 | Hemostatic | 0.394 0.008 CID_11522049 | CID_11522049 | |
| 0.057 | 0.038 | 0.057 | Leukotriene C antagonist | |||
| 0.067 | 0.048 | 0.067 | MDM2 inhibitor | |||
| 0.083 | 0.065 | 0.083 | Hematopoietic | |||
| 0.057 | 0.039 | 0.057 | Beta 1 adrenoreceptor antagonist | |||
| 0.04 | 0.022 | 0.04 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.043 | 0.025 | 0.043 | Kainate receptor agonist | |||
| 0.051 | 0.034 | 0.051 | Beta 2 adrenoreceptor antagonist | |||
| 0.023 | 0.006 | 0.023 | Thyroid hormone alpha antagonist | |||
| 0.021 | 0.005 | 0.021 | Egl nine homolog 1 inhibitor | |||
| 0.049 | 0.034 | 0.049 | Dopamine beta hydroxylase inhibitor | |||
| 0.043 | 0.029 | 0.055 | Guanylate cyclase inhibitor | 0.055 0.016 CID_11522049 | CID_11522049 | |
| 0.062 | 0.049 | 0.115 | Neuraminidase (influenza) inhibitor | 0.115 0.013 CID_11522049 | CID_11522049 | |
| 0.035 | 0.022 | 0.035 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.069 | 0.056 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.068 | 0.056 | 0.068 | Aminopeptidase I inhibitor | |||
| 0.093 | 0.081 | 0.093 | DNA intercalator | |||
| 0.08 | 0.068 | 0.08 | Ornithine decarboxylase inhibitor | |||
| 0.032 | 0.021 | 0.032 | HCV NS5B polymerase inhibitor | |||
| 0.059 | 0.048 | 0.059 | Heme oxygenase stimulant | |||
| 0.044 | 0.033 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.221 | 0.211 | 0.221 | DNA directed DNA polymerase inhibitor | |||
| 0.055 | 0.045 | 0.226 | HIV-1 integrase (Strand Transfer) inhibitor | 0.226 0.008 CID_11522049 | CID_11522049 | |
| 0.022 | 0.013 | 0.022 | Prostaglandin EP1 antagonist | |||
| 0.047 | 0.038 | 0.047 | Prostaglandin E2 antagonist | |||
| 0.034 | 0.024 | 0.034 | RNA-directed RNA polymerase inhibitor | |||
| 0.154 | 0.145 | 0.154 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.151 | 0.143 | 0.22 | Platelet antagonist | 0.22 0.088 CID_11522049 | CID_11522049 | |
| 0.045 | 0.037 | 0.045 | AMPA receptor antagonist | |||
| 0.075 | 0.068 | 0.075 | Calcium antagonist | |||
| 0.022 | 0.016 | 0.022 | Beta 1 adrenoreceptor agonist | |||
| 0.034 | 0.028 | 0.034 | Glutamate (mGluR8) antagonist | |||
| 0.099 | 0.093 | 0.099 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.04 | 0.035 | 0.04 | DNA gyrase subunit A inhibitor | |||
| 0.067 | 0.062 | 0.067 | Glycine receptor agonist | |||
| 0.01 | 0.005 | 0.01 | Thyroid hormone beta agonist | |||
| 0.007 | 0.004 | 0.007 | Insulin like growth factor 3 antagonist | |||
| 0.094 | 0.09 | 0.094 | Adenylate cyclase inhibitor | |||
| 0.012 | 0.009 | 0.012 | Egl nine homolog 3 inhibitor | |||
| 0.059 | 0.057 | 0.059 | Cyclin B3 inhibitor | |||
| 0.036 | 0.034 | 0.036 | Retinoic acid alpha receptor agonist | |||
| 0.134 | 0.133 | 0.426 | Angiogenesis stimulant | 0.426 0.018 CID_11522049 | CID_11522049 | |
| 0.037 | 0.035 | 0.037 | Leukotriene C4 antagonist | |||
| 0.035 | 0.034 | 0.035 | Kainate receptor antagonist | |||
| 0.129 | 0.128 | 0.129 | Amyloid beta precursor protein antagonist | |||
| 0.163 | 0.162 | 0.163 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.055 | 0.065 | 0.062 | Protease 3C (Human rhinovirus) inhibitor | 0.062 0.048 CID_11522049 | CID_11522049 | |
| 0.021 | 0.032 | 0.126 | NMDA 2D receptor antagonist | 0.126 0.003 CID_11522049 | CID_11522049 | |
| 0.045 | 0.055 | 0.295 | NMDA 2B receptor antagonist | 0.295 0.004 CID_11522049 | CID_11522049 | |
| 0.056 | 0.07 | 0.12 | Catalase inhibitor | 0.12 0.033 CID_11522049 | CID_11522049 | |
| 0.026 | 0.041 | 0.054 | Purinergic P2Y2 antagonist | 0.054 0.009 CID_11522049 | CID_11522049 | |
| 0.058 | 0.072 | 0.2 | Carbonic anhydrase XIII inhibitor | 0.2 0.014 CID_11522049 | CID_11522049 | |
| 0.046 | 0.063 | 0.079 | Neuraminidase inhibitor | 0.079 0.026 CID_11522049 | CID_11522049 | |
| 0.028 | 0.049 | 0.048 | Dopamine D2 agonist | 0.048 0.028 CID_11522049 | CID_11522049 | |
| 0.029 | 0.05 | 0.078 | Factor XIa inhibitor | 0.078 0.008 CID_11522049 | CID_11522049 | |
| 0.105 | 0.129 | 0.196 | Thrombolytic | 0.196 0.054 CID_11522049 | CID_11522049 | |
| 0.084 | 0.112 | 0.121 | Cholesterol synthesis inhibitor | 0.121 0.065 CID_11522049 | CID_11522049 | |
| 0.052 | 0.081 | 0.072 | Na+ K+ transporting ATPase inhibitor | 0.072 0.058 CID_11522049 | CID_11522049 | |
| 0.057 | 0.087 | 0.075 | Phospholipase D inhibitor | 0.075 0.043 CID_11522049 | CID_11522049 | |
| 0.014 | 0.045 | 0.021 | Dopamine D1 agonist | 0.021 0.02 CID_11522049 | CID_11522049 | |
| 0.017 | 0.05 | 0.026 | Glutamate (mGluR1) agonist | 0.026 0.014 CID_11522049 | CID_11522049 | |
| 0.052 | 0.085 | 0.141 | Cathepsin G inhibitor | 0.141 0.022 CID_11522049 | CID_11522049 | |
| 0.069 | 0.104 | 0.125 | Breast cancer-resistant protein inhibitor | 0.125 0.036 CID_11522049 | CID_11522049 | |
| 0.012 | 0.053 | 0.029 | Glutamate (mGluR1a) agonist | 0.029 0.009 CID_11522049 | CID_11522049 | |
| 0.012 | 0.056 | 0.032 | Kynurenine 3 monooxygenase inhibitor | 0.032 0.014 CID_11522049 | CID_11522049 | |
| 0.028 | 0.074 | 0.044 | Mannosidase inhibitor | 0.044 0.034 CID_11522049 | CID_11522049 | |
| 0.037 | 0.089 | 0.069 | Heparanase inhibitor | 0.069 0.012 CID_11522049 | CID_11522049 | |
| 0.043 | 0.096 | 0.114 | Carbonic anhydrase VA inhibitor | 0.114 0.02 CID_11522049 | CID_11522049 | |
| 0.035 | 0.09 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.043 CID_11522049 | CID_11522049 | |
| 0.024 | 0.083 | 0.068 | Carbonic anhydrase VB inhibitor | 0.068 0.029 CID_11522049 | CID_11522049 | |
| 0.036 | 0.101 | 0.159 | Carbonic anhydrase V inhibitor | 0.159 0.013 CID_11522049 | CID_11522049 | |
| 0.066 | 0.134 | 0.097 | Protein kinase C zeta inhibitor | 0.097 0.055 CID_11522049 | CID_11522049 | |
| 0.017 | 0.085 | 0.066 | Estrogen agonist | 0.066 0.028 CID_11522049 | CID_11522049 | |
| 0.101 | 0.173 | 0.429 | Platelet adhesion inhibitor | 0.429 0.009 CID_11522049 | CID_11522049 | |
| 0.021 | 0.108 | 0.136 | Leukocyte elastase inhibitor | 0.136 0.006 CID_11522049 | CID_11522049 | |
| 0.15 | 0.239 | 0.404 | Angiogenesis inhibitor | 0.404 0.052 CID_11522049 | CID_11522049 | |
| 0.006 | 0.107 | 0.69 | Cholecystokinin A agonist | 0.69 0.002 CID_11522049 | CID_11522049 | |
| 0.148 | 0.255 | 0.299 | Antithrombotic | 0.299 0.089 CID_11522049 | CID_11522049 | |
| 0.005 | 0.119 | 0.032 | Estrone sulfatase inhibitor | 0.032 0.01 CID_11522049 | CID_11522049 | |
| 0.006 | 0.122 | 0.724 | Cholecystokinin agonist | 0.724 0.002 CID_11522049 | CID_11522049 | |
| 0.018 | 0.142 | 0.665 | Cholecystokinin B agonist | 0.665 0.001 CID_11522049 | CID_11522049 | |
| 0.012 | 0.143 | 0.053 | Factor XI inhibitor | 0.053 0.009 CID_11522049 | CID_11522049 | |
| 0.005 | 0.143 | 0.376 | Cholecystokinin A antagonist | 0.376 0.003 CID_11522049 | CID_11522049 | |
| 0.014 | 0.16 | 0.056 | Carbonic anhydrase inhibitor | 0.056 0.049 CID_11522049 | CID_11522049 | |
| 0.052 | 0.215 | 0.225 | Multidrug resistance-associated protein 1 inhibitor | 0.225 0.006 CID_11522049 | CID_11522049 | |
| 0.006 | 0.186 | 0.32 | Cholecystokinin antagonist | 0.32 0.004 CID_11522049 | CID_11522049 | |
| 0.017 | 0.22 | 0.167 | Selectin antagonist | 0.167 0.015 CID_11522049 | CID_11522049 | |
| 0.004 | 0.241 | 0.277 | Cholecystokinin B antagonist | 0.277 0.004 CID_11522049 | CID_11522049 | |
| 0.007 | 0.248 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.035 0.006 CID_11522049 | CID_11522049 | |
| 0.156 | 0.405 | 0.392 | Antiinflammatory | 0.392 0.144 CID_11522049 | CID_11522049 | |
| 0.012 | 0.392 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 CID_11522049 | CID_11522049 | |
| 0.011 | 0.393 | 0.089 | Elastase inhibitor | 0.089 0.013 CID_11522049 | CID_11522049 | |
| 0.029 | 0.45 | 0.102 | Nav1.4 sodium channel blocker | 0.102 0.073 CID_11522049 | CID_11522049 | |
| 0.025 | 0.483 | 0.445 | Anticoagulant | 0.445 0.013 CID_11522049 | CID_11522049 | |
| 0.037 | 0.596 | 0.286 | Antiobesity | 0.286 0.126 CID_11522049 | CID_11522049 | |
| 0.005 | 0.863 | 0.066 | Thrombin inhibitor | 0.066 0.061 CID_11522049 | CID_11522049 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |